Transform Your Pharmacy’s Growth Potential with ACHC and Monarch Specialty Group. Click Here to learn more

US Market Size

Projected US demand of targeted biologics by 2020

Average Net Cost

Per prescription, 2014, a 14% increase over prior year

FDA Biologics Pipeline

Percentage biologics vs. total number of drugs currently in development

Orphan Drug Approvals

FDA drug approvals, 2014, a 53% increase over prior year

*American Pharmacists Association, Jan 2015*Report on Prescription Drug Costs, Prime Therapeutics 2014*Pharmaceutical Research and Manufacturers of America, 2015*FDA Orphan Drug Product Designation Database, accessed Sept. 2015

Our Services

We work with U.S. based pharmaceutical manufacturers, pharmacy companies, and investor stakeholders of orphan drugs and related specialty biologics to tackle market access and business development challenges in three practice areas:

Our Pharma Market Access Practice assists pharmaceutical manufacturers to identify, implement, and support simple, powerful solutions for optimized market access on behalf of orphan drugs and related complex specialty biologics.

Our work encompasses a wide range of core competencies, including:

  • Commercial Pre/Post Launch Planning and Market Preparation
  • Launch and In-Market Optimization
  • Drug Pricing and Value Communication
  • Payor Access, Contracting, and Segmentation
  • Supply Chain, Distribution and Channel Strategy
  • Hub Service Model Design and Configuration
  • Reimbursement Services
  • Patient Assistance Programs
  • Clinical Support Program Design and Implementation
  • Data Analytics and Reporting

Our subsector specialization includes:

  • Specialty Pharmaceuticals
  • Biosimilars and Generics
  • Medical Device

Our clients benefit from relevant solutions combining:

  • Actionable “know-how” of advanced product/service model solutions for biologics with direct hands-on product distribution experience with every major FDA-approved biologic drug
  • Ability to partner with executives and operations management teams across our full range of market access competencies
  • Rigorous execution delivered with responsive and agile service
Our Pharmacy Distributor Practice supports middle-market pharmacy companies and related healthcare service firms in connection with business development, sales and operations support specific to the specialty pharmacy sector.

Our work encompasses a wide range of core competencies, including:

  • Managed Markets Sales and Contracting
  • Drug Purchasing and Trade Relations Administration
  • Clinical Programs Development
  • Positioning and Product Service Communications
  • Specialty Data Integration and Reporting
  • Contract Administration

Our subsector specialization includes:

  • Specialty Pharmacy
  • Home Infusion Pharmacy
  • Retail Pharmacy
  • Hospital/Physician Practice Dispensing
  • Healthcare IT

Our clients benefit from bespoke solutions combining:

  • Full-scale commercial operations support that takes into account each client’s sales, payor, trade relations and financial goals and concerns
  • Innovative partner relationships to address regional market challenges, and ability to scale advanced commercial solutions to a local, regional or national level
  • Access to proprietary deal flow

Through our M&A Advisory Practice we work with a broad range of clients, including specialty pharmacy corporations, private equity institutions and venture capital financial sponsors to provide strategic advisory and related support applicable to valuation and M&A transactions within the specialty pharmacy and larger healthcare industry.

This includes extensive experience with a broad range of partnership structures and transaction needs, including:

  • Mergers
  • Acquisitions
  • Facilitated Partnerships
  • Valuations & Diligence
  • Joint Ventures
  • Organizational Integration
  • Restructuring & Divestiture
  • Special Purpose Acquisition (SPAC)
Through our M&A Advisory Practice we work with a broad range of clients, including specialty pharmacy corporations, private equity institutions and venture capital financial sponsors to provide strategic advisory and related support applicable to valuation and M&A transactions within the specialty pharmacy and larger healthcare industry.

This includes extensive experience with a broad range of partnership structures and transaction needs, including:

  • Mergers
  • Acquisitions
  • Facilitated Partnerships
  • Valuations & Diligence
  • Joint Ventures
  • Organizational Integration
  • Restructuring & Divestiture
  • Special Purpose Acquisition (SPAC)

Who We Work With

Monarch Specialty Group commonly works with executives from bio/pharmaceutical manufacturers, specialty pharmacies, healthcare technology providers, PE/venture capital, and other industry stakeholders with responsibilities or involvement in the following areas:

  • CEO/COO/President/Director
  • Patient Access, Services, Solutions
  • Product/Brand Management
  • Reimbursement
  • Market Analyst
  • Payer Strategy/Managed Markets
  • Specialty Services, Channels and Distribution
  • SPP Strategy and Innovation
  • New Products/Commercial Operations
  • Pharmacy Operations

Our success centers on value creation and gain realization for our clients seeking long-term market outperformance.

The result? Improved business security and market outperformance.